tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), 10x Genomics (TXG) and LivaNova (LIVN)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Bausch + Lomb Corporation (BLCOResearch Report), 10x Genomics (TXGResearch Report) and LivaNova (LIVNResearch Report).

Bausch + Lomb Corporation (BLCO)

Stifel Nicolaus analyst Thomas Stephan maintained a Hold rating on Bausch + Lomb Corporation yesterday and set a price target of $15.00. The company’s shares closed last Thursday at $13.86, close to its 52-week low of $13.62.

According to TipRanks.com, Stephan is a 4-star analyst with an average return of 21.8% and a 75.0% success rate. Stephan covers the Healthcare sector, focusing on stocks such as Staar Surgical, Sight Sciences, and RxSight.

Currently, the analyst consensus on Bausch + Lomb Corporation is a Moderate Buy with an average price target of $18.86, representing a 35.7% upside. In a report issued on May 1, Needham also maintained a Hold rating on the stock.

See Insiders’ Hot Stocks on TipRanks >>

10x Genomics (TXG)

Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on 10x Genomics yesterday and set a price target of $53.00. The company’s shares closed last Thursday at $26.29, close to its 52-week low of $24.60.

According to TipRanks.com, Arias has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -9.2% and a 38.3% success rate. Arias covers the Healthcare sector, focusing on stocks such as Maravai Lifesciences Holdings, Guardant Health, and Mettler-Toledo.

10x Genomics has an analyst consensus of Moderate Buy, with a price target consensus of $45.91, which is a 66.8% upside from current levels. In a report issued on April 18, Deutsche Bank also maintained a Buy rating on the stock with a $55.00 price target.

LivaNova (LIVN)

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on LivaNova yesterday and set a price target of $70.00. The company’s shares closed last Thursday at $62.92, close to its 52-week high of $63.21.

According to TipRanks.com, Wise is a 4-star analyst with an average return of 4.6% and a 58.1% success rate. Wise covers the Healthcare sector, focusing on stocks such as Treace Medical Concepts, Baxter International, and Edwards Lifesciences.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for LivaNova with a $72.38 average price target, a 15.6% upside from current levels. In a report issued on May 1, Needham also maintained a Buy rating on the stock with a $72.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on BLCO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles